Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 13, 2026

Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision
07:22

Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision

Published on: June 13, 2025

Initial experiences with robot-assisted laparoscopic radical cystectomy.

Se-Yun Kwon1, Bum Soo Kim, Tae-Hwan Kim

  • 1Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.

Korean Journal of Urology
|April 24, 2010
PubMed
Summary

Robot-assisted radical cystectomy (RLRC) with extracorporeal urinary diversion is a safe and feasible treatment for muscle-invasive bladder cancer, showing minimal blood loss and quick recovery in initial patient experiences.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioinstructive Hybrid Scaffold Integrating Phosphoinositide 3-Kinase-Akt and Complementary Survival Pathways for Kidney Regeneration.

ACS nano·2026
Same author

Hematite is a mineralogical marker of ancient climate change on Mars.

Science (New York, N.Y.)·2026
Same author

Multifunctional Biomaterial Strategies to Regulate Inflammation and Promote Kidney Repair.

Biomaterials research·2026
Same author

Diagnostic performance of multiparametric imaging markers in differentiating local recurrence from post-treatment change in head and neck cancer surveillance.

Neuroradiology·2026
Same author

Verification of renal tissue regeneration using human perinephric fat-derived collagen sheet in a partially nephrectomized animal model.

Journal of biomaterials applications·2025
Same author

Anti-Oxidative and Anti-Inflammatory Effect of Protaetia Brevitarsis-Derived Protein Hydrolysates in Adipose Tissues of Obese Mice.

International journal of molecular sciences·2025

Area of Science:

  • Urology
  • Surgical Oncology
  • Minimally Invasive Surgery

Background:

  • Muscle-invasive bladder cancer requires radical cystectomy.
  • Robot-assisted laparoscopic radical cystectomy (RLRC) is an emerging surgical option.
  • Extracorporeal urinary diversion is a common reconstructive technique.

Purpose of the Study:

  • To report the operative technique and initial clinical experiences with RLRC.
  • To evaluate the safety and feasibility of RLRC with extracorporeal urinary diversion.
  • To assess early postoperative outcomes in patients undergoing RLRC.

Main Methods:

  • A prospective case series of 17 patients with muscle-invasive bladder cancer.
  • All patients underwent RLRC, pelvic lymph node dissection, and extracorporeal urinary diversion (13 ileal conduits, 4 orthotopic neobladders).
Keywords:
CystectomyRoboticsUrinary bladder neoplasms

Related Experiment Videos

Last Updated: Jun 13, 2026

Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision
07:22

Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision

Published on: June 13, 2025

  • Data collected included demographics, operative parameters, and postoperative outcomes.
  • Main Results:

    • Mean operative time was 379.1 minutes.
    • Mean estimated blood loss was 210.5 ml.
    • Mean hospital stay was 20.7 days, with rapid return to oral intake and ambulation; no major perioperative complications were observed.

    Conclusions:

    • RLRC with pelvic lymph node dissection and extracorporeal urinary diversion is safe and feasible.
    • The procedure is associated with minimal blood loss and rapid patient recovery.
    • Further long-term follow-up in a larger cohort is necessary to confirm oncological and functional benefits.